INVO Fertility (IVF) Net Income towards Common Stockholders (2011 - 2025)

INVO Fertility has disclosed Net Income towards Common Stockholders across 15 years of filings, most recently posting -$2.6 million for Q3 2025.

• Quarterly Net Income towards Common Stockholders fell 62.18% year-over-year to -$2.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$42.7 million (down 504.51% YoY) and the FY2024 annual result came in at -$9.3 million, down 16.33% from the prior year.
• Net Income towards Common Stockholders improved to -$2.6 million in Q3 2025, from -$5.3 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $101782.0 in Q4 2021 and bottomed at -$17.4 million in Q1 2025.
• The 5-year median for Net Income towards Common Stockholders is -$2.5 million (2021), against an average of -$3.2 million.
• Year-over-year, Net Income towards Common Stockholders soared 102.67% in 2021 and sank 2818.28% in 2022.
• INVO Fertility's Net Income towards Common Stockholders stood at $101782.0 in 2021, then sank by 2818.28% to -$2.8 million in 2022, then rose by 27.9% to -$2.0 million in 2023, then tumbled by 94.21% to -$3.9 million in 2024, then jumped by 31.74% to -$2.6 million in 2025.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$2.6 million, -$5.3 million, and -$17.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.